Creatine Study Results

CREATINE STUDY AT TWO MAJOR UNIVERSITIES REVEALS DRAMATIC NEW DATA IN PLASMA UPTAKE

In over twenty years of peer-reviewed scientific studies performed on creatine by major universities abroad and in the United States, the common denominator has been:  when creatine monohydrate is dosed properly, it will provide as much or more desired performance enhancement (increased strength and recovery) as any of the subsequent creatine “improvements”.

Despite not being very bio-available or soluble, Creatine monohydrate has been the most steadfast supplement in the sports nutrition industry simply because nothing else has been developed that has been shown to actually be better - despite the claims of other supplements. In an industry that is largely unregulated, some supplement companies have been involved in shallow or “creative” science in order to back-up product claims, but when subjected to real scientific methods, little or no evidence of improvement is found.

When the CON-CRĒT molecule was first introduced in 2007, it was hailed as a breakthrough in creatine science. For the first time, a creatine molecule was developed that was so bio-available it allowed users to dose on body weight like a pharmaceutical compound does (no other creatine product does this) and to catalyze dramatic performance enhancement.

However, sports nutritionists were understandably skeptical of another new “improvement.”
That’s why ProMera Health looked to two major Universities to assist in conducting a full double blind, placebo-controlled, balanced cross-over plasma uptake study to expand understanding of and scientifically document the comparative performance of CON-CRĒT vs. creatine monohydrate and other top selling creatines. 

The task for the universities was to measure human volunteer subjects specifically dosed with different forms of creatine and then test and evaluate absorption in the bloodstream.

The results were clear.  For the first time in 20 years of formal academic creatine research – and using standard FDA testing methods – tests showed convincing evidence of a significant improvement in plasma uptake of a creatine. In addition, peak creatine plasma concentrations and plasma area under the curve (AUC) were significantly greater in the CON-CRĒT treatment phase and CON-CRĒT’s relative bioavailability was found to be over 60% greater than that of creatine monohydrate. 

The reason solubility is such a big deal is simple —if creatine it isn’t in solution (soluble), it won’t be absorbed into the bloodstream. Creatines vary in performance largely based on solubility.

Together these studies demonstrate that CON-CRĒT provides a more efficient form of creatine with improved oral absorption properties.  Clearly, CON-CRĒT has revolutionized the creatine market and truly makes all other creatines obsolete.